Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masujiro Makita is active.

Publication


Featured researches published by Masujiro Makita.


Japanese Journal of Cancer Research | 1992

Clinicopathologic Characteristics and Prognosis of Breast Cancer Patients Associated with Pregnancy and Lactation: Analysis of Case-Control Study in Japan

Tsunehiro Ishida; Takao Yokoe; Fujio Kasumi; Goi Sakamoto; Masujiro Makita; Takeshi Tominaga; Kohjiro Simozuma; Kohji Enomoto; Kiyoshi Fujiwara; Takeshi Nanasawa; Takashi Fukutomi; Teruyuki Hirota; Mamoru Fukuda; Shigeto Miura; Hiroki Koyama; Hideo Inaji; Hiroshi Sonoo

Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation were clarified by means of a case‐control study of matched non‐pregnant and non‐lactating patients with breast cancer. From 18 institutions in Japan, a total of 192 subjects with breast cancer diagnosed during pregnancy (72 cases) and lactation (120 cases) were collected between 1970 and 1988, accounting for 0.76% of all breast cancer patients. The duration of symptoms was longer and tumor size was larger in the study subjects. Although the disease‐free interval was longer than that in the control patients, the survival time was shorter. There was no characteristic difference in histologic type. Vascular invasion and lymph node metastasis were found more frequently in the subjects. The positive rates of estrogen receptor and progesterone receptor were lower in the subjects. The 5‐ and 10‐year survival rates of the study patients were 65% and 55%, respectively, and these survivals were significantly lower than those of the control (P < 0.001). The survival rates were poorer in the subjects, in accordance with stage and lymph node metastasis. The results suggest that most of the patients with breast cancer diagnosed during pregnancy and lactation are in a more advanced stage because of a delay in detection and diagnosis, and hence have unfavorable prognosis. Therefore, it is important to diagnose and treat early for improvement of prognosis in patients with breast cancer during pregnancy and lactation.


Breast Cancer Research and Treatment | 2000

Surgical treatment of hepatic metastases from breast cancer.

Masataka Yoshimoto; Takashi Tada; Mitsue Saito; Kaoru Takahashi; Masujiro Makita; Yoshihiro Uchida; Fujio Kasumi

We have performed a retrospective study to evaluate whether surgical treatment is beneficial in patients with hepatic metastases from breast cancer. Between September 1985 and September 1998, 25 patients with hepatic metastases (14 solitary and 11 multiple), eight of whom had extrahepatic metastases, underwent hepatectomy. All of the detectable liver metastasis were resected in all of the cases. There were no severe postoperative complications. All but one of the patients received adjunctive polychemotherapy after the hepatectomy. After the hepatectomy, recurrent tumors were detected in 18 of the patients, being located in the liver in 12 (67%) of them. Overall, however, hepatectomy ensured that the liver was clinically recurrence-free for a median of 24 months (range 2–132 months). Eleven patients died of recurrent tumors, two died of other causes and the remaining 12 are currently alive. The 2- and 5-year cumulative survival rates after hepatectomy were 71% and 27%, respectively, and the median survival duration was 34.3±3.2 months, much better than the period of 8.5 months for another series of patients treated with standard or non-surgical therapies at our institution. The number and the size of hepatic metastases, the interval between treatment of the primary lesion and hepatectomy, and the existence of extrahepatic metastasis were not adverse prognostic factors. In conclusion, our data, although limited and highly selective, suggest that surgical treatment of hepatic metastases from breast cancer may prolong survival in certain subgroups of patients to a greater extent than standard or non-surgical therapies.


Breast Cancer Research and Treatment | 1991

Duct endoscopy and endoscopic biopsy in the evaluation of nipple discharge

Masujiro Makita; Goi Sakamoto; Futoshi Akiyama; Kiyoshi Namba; Haruo Sugano; Fujio Kasumi; Mitsumasa Nishi; Motoko Ikenaga

SummaryMicrodochectomy is usually performed on patients with nipple discharge caused by intraductal proliferative lesions, such as intraductal papilloma and carcinoma. But this operation often sacrifices large amounts of normal mammary gland even when the lesion is a benign intraductal papilloma a few millimeters in diameter. We have developed duct endoscopy for the mammary duct system, and have reliably performed biopsies for intraductal proliferative lesions intraductally. From June 1989 to April 1990, we examined 22 cases by duct endoscopy, and performed endoscopic biopsy in 16 cases. The method of endoscopic biopsy is as follows. First, a bougie is inserted, without anesthesia other than Xylocaine jelly, into the orifice of the duct to enlarge it. Second, the outer cylinder and the inner needle are inserted; then the inner needle is removed, and the endoscope is inserted. After examination, the outer cylinder is moved up to the lesion to be biopsied and the endoscope is taken out. Then a sample is taken into the outer cylinder by aspiration. We diagnosed 10 cases of benign lesion and 5 cases of malignant lesion by cytological and/or histological examination. In conclusion, endoscopic biopsy, aided by duct endoscopy, is a useful and harmless diagnostic procedure in the evaluation of nipple discharge.


Human Pathology | 2010

Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications

Rin Yamaguchi; Rie Horii; Ichiro Maeda; Sachie Suga; Masujiro Makita; Takuji Iwase; Masahiko Oguchi; Yoshinori Ito; Futoshi Akiyama

Metaplastic carcinoma of the breast is a relatively rare cancer and includes various histologic types. In this cancer, metaplastic elements are heterogeneous and sometimes mixed. We investigated, by histopathologic means, these elements and clinical implications that could indicate the clinical course (including the prognosis). Fifty-three metaplastic breast carcinoma cases and their prognoses were investigated by initially examining the presence or absence of spindle-cell elements, and then the presence or absence of other elements. Spindle cells were classified as high or low grade. The number of spindle-cell-positive cases was 24 (45%) of 53. The 24 spindle-cell (+) cases were subdivided into 12 high-grade (HGsp) (distant metastatic rate per 100 person-years, 13.27) and 12 low-grade (LGsp) (0.00) patients. Spindle-cell (-) cases were subdivided into 22 pure squamous cell carcinomas (5.93) and 7 matrix-producing carcinomas (0.00). There were significant differences among the 4 groups with regard to the disease-free period (P = .0081, log-rank test). The distant metastatic risks in the HGsp and pure squamous cell carcinomas groups were significantly higher than that in the matrix-producing carcinoma + LGsp group (nonmetastatic groups) after controlling for the effects of tumor size and lymph node metastasis (P = .019 and P = .016, respectively, Poisson regression model). The presence of high-grade spindle cells was related to the prognosis, and some histologic subtypes may be important with respect to the prognosis. The presence of high-grade spindle cells in metaplastic breast carcinoma may indicate aggressive behavior.


Journal of Human Genetics | 1998

High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families

Toyomasa Katagiri; Fujio Kasumi; Masataka Yoshimoto; Tadashi Nomizu; Kazuaki Asaishi; Rikiya Abe; Atsuo Tsuchiya; Masahiko Sugano; Shin-ichiro Takai; Mitsusato Yoneda; Takashi Fukutomi; Kiyoshi Nanba; Masujiro Makita; Hiroshi Okazaki; Kouichi Hirata; Minoru Okazaki; Yoshikazu Furutsuma; Yasuo Morishita; Y Iino; Takayuki Karino; Hiroyoshi Ayabe; Shinsuke Hara; Tetsuro Kajiwara; Syunsuke Houga; Tadao Shimizu; Masakazu Toda; Youji Yamazaki; Takashi Uchida; Kazufumi Kunitomo; Hiroshi Sonoo

AbstractMutations in either of two recently identified genes, BRCA1 and BRCA2, are thought to be responsible for approximately two-thirds of all cases of autosomal-dominantly inherited breast cancer. To examine the nature and frequency of BRCA1 and BRCA2 mutations in Japanese families exhibiting a high incidence of breast cancer, we screened 78 unrelated families in this category for mutations of these two genes. Examining the entire coding sequences as well as exon–intron boundaries of both genes by polymerase chain reaction (PCR) single-strand conformation polymorphism (SSCP) and multiplex-SSCP analysis, we identified possible disease-causing alterations in BRCA1 among affected members of 15 families and in BRCA2 in another 14 families. In 15 of those 29 families, the affected individuals carried missense mutations, although most germline mutations reported worldwide have been deletions or nonsense mutations. Our results, indicating that missense mutations of BRCA1 and BRCA2 tend to predominate over frameshifts or nonsense mutations in Japanese breast cancer families, will contribute signifi-cantly to an understanding of mammary tumorigenesis in Japan, and will be of vital importance for future genetic testing.


Breast Cancer | 2002

Endoscopic classification of intraductal lesions and histological diagnosis

Masujiro Makita; Futoshi Akiyama; Naoya Gomi; Motoko Ikenaga; Masataka Yoshimoto; Fujio Kasumi; Goi Sakamoto

BackgroundTo diagnose intraductal lesions endoscopically the Japanese Association of Mammary Ductoscopy classified the endoscopical appearance of lesions into three types. We investigated the correlation between endoscopic classification and histological diagnosis.MethodsFrom April 1998 to February 2001, we enrolled 129 female patients who were diagnosed histologically and whose intraductal lesions were detected by mammary ductoscopy. The endoscopic classification consists of three types. The polypoid type is a localized expansive lesion. This type is divided into two subtypes, the solitary subtype (solitary polypoid lesion) and the multiple subtype (multiple polypoid lesions). The combined type is polypoid lesion(s) coexisting with a superficial type. The superficial type is a superficial spreading lesion such as a continuous luminal irregularity accompanied by no obvious elevations.ResultsThere were 65 cases of breast cancer and 64 cases of benign papillary lesions. Fifty-four cases of benign papillary lesions and 7 cases of breast cancer were classified as the polypoid-solitary type. Seven benign cases and 13 cases of cancer were classified as the polypoid-multiple type. Two benign cases and 16 cases of cancer were classified as the combined type. Only one benign case and 29 cases of cancer were classified as the superficial type. There is significant correlation between endoscopical types and the histological diagnosis (p < 0.0001).ConclusionsEndoscopic classification is useful to diagnose intraductal lesions.


World Journal of Surgical Oncology | 2010

Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer

Keiichiro Tada; Akiko Ogiya; Kiyomi Kimura; Hidetomo Morizono; Kotaro Iijima; Yumi Miyagi; Seiichiro Nishimura; Masujiro Makita; Rie Horii; Futoshi Akiyama; Takuji Iwase

BackgroundThe impact of sentinel lymph node biopsy on breast cancer mimicking ductal carcinoma in situ (DCIS) is a matter of debate.MethodsWe studied the rate of occurrence of sentinel lymph node metastasis in 255 breast cancer patients with pure DCIS showing no invasive components on routine pathological examination. We compared this to the rate of occurrence in 177 patients with predominant intraductal-component (IDC) breast cancers containing invasive foci equal to or less than 0.5 cm in size.ResultsMost of the clinical and pathological baseline characteristics were the same between the two groups. However, peritumoral lymphatic permeation occurred less often in the pure DCIS group than in the IDC-predominant invasive-lesion group (1.2% vs. 6.8%, p = 0.002). One patient (0.39%) with pure DCIS had two sentinel lymph nodes positive for metastasis. This rate was significantly lower than that in patients with IDC-predominant invasive lesions (6.2%; p < 0.001).ConclusionsBecause the rate of sentinel lymph node metastasis in pure DCIS is very low, sentinel lymph node biopsy can safely be omitted.


Surgery Today | 1995

Histopathological study of local residual carcinoma after simulated lumpectomy

Shunsuke Haga; Masujiro Makita; Tadao Shimizu; Osamu Watanabe; Hiroshi Imamura; Tetsuro Kajiwara; Mariko Fujibayashi

From 1989 to 1991, 24 patients with invasive ductal carcinoma underwent simulated lumpectomy at Tokyo Womens Medical College Daini Hospital. The mastectomy specimens were then examined histopathologically in serial sections for the presence of residual tumors or multicentricity. Lumpectomy specimens from cancer foci at resected margins were also examined. In this study, 23 of 24 patients demonstrated positive resection margins (95.8%). Residual tumors were found in mastectomy specimens from 16 patients (66.7%); unilateral multifocal carcinomas were found in 2 of these patients (8.3%). The incidence and severity of residual tumors did not correlate with primary tumor size or the distance between the nipple and the primary tumor but directly correlated with the severity of intraductal spread of the primary tumor. Tumors with central necrosis were associated with a higher incidence of residual tumors. Our study thus indicates that there is a high risk that some residual tumor will be left in the conserved breast when lumpectomy is performed. Multifocal carcinoma and tumors showing severe intraductal spread and central necrosis are thus associated with extensive residual tumors and are likely to cause local recurrence.


World Journal of Surgical Oncology | 2006

Frozen section is superior to imprint cytology for the intra-operative assessment of sentinel lymph node metastasis in Stage I Breast cancer patients

Miki Mori; Keiichiro Tada; Motoko Ikenaga; Yumi Miyagi; Seiichiro Nishimura; Kaoru Takahashi; Masujiro Makita; Takuji Iwase; Fujio Kasumi; Mituru Koizumi

BackgroundA standard intra-operative procedure for assessing sentinel lymph node metastasis in breast cancer patients has not yet been established.Patients and methodsOne hundred and thirty-eight patients with stage I breast cancer who underwent sentinel node biopsy using both imprint cytology and frozen section were analyzed.ResultsSeventeen of the 138 patients had sentinel node involvement. Results of imprint cytology included nine false negative cases (sensitivity, 47.1%). In contrast, only two cases of false negatives were found on frozen section (sensitivity, 88.2%). There were two false positive cases identified by imprint cytology (specificity, 98.3%). On the other hand, frozen section had 100% specificity.ConclusionThese findings suggest that frozen section is superior to imprint cytology for the intra-operative determination of sentinel lymph node metastasis in stage I breast cancer patients.


International Journal of Radiation Oncology Biology Physics | 2012

Influence of Lymphatic Invasion on Locoregional Recurrence Following Mastectomy: Indication for Postmastectomy Radiotherapy for Breast Cancer Patients With One to Three Positive Nodes

Ryoichi Matsunuma; Masahiko Oguchi; Tomoko Fujikane; Masaaki Matsuura; Takehiko Sakai; Kiyomi Kimura; Hidetomo Morizono; Kotaro Iijima; Ayumi Izumori; Yumi Miyagi; Seiichiro Nishimura; Masujiro Makita; Naoya Gomi; Rie Horii; Futoshi Akiyama; Takuji Iwase

PURPOSE The indication for postmastectomy radiotherapy (PMRT) in breast cancer patients with one to three positive lymph nodes has been in discussion. The purpose of this study was to identify patient groups for whom PMRT may be indicated, focusing on varied locoregional recurrence rates depending on lymphatic invasion (ly) status. METHODS AND MATERIALS Retrospective analysis of 1,994 node-positive patients who had undergone mastectomy without postoperative radiotherapy between January 1990 and December 2000 at our hospital was performed. Patient groups for whom PMRT should be indicated were assessed using statistical tests based on the relationship between locoregional recurrence rate and ly status. RESULTS Multivariate analysis showed that the ly status affected the locoregional recurrence rate to as great a degree as the number of positive lymph nodes (p < 0.001). Especially for patients with one to three positive nodes, extensive ly was a more significant factor than stage T3 in the TNM staging system for locoregional recurrence (p < 0.001 vs. p = 0.295). CONCLUSION Among postmastectomy patients with one to three positive lymph nodes, patients with extensive ly seem to require local therapy regimens similar to those used for patients with four or more positive nodes and also seem to require consideration of the use of PMRT.

Collaboration


Dive into the Masujiro Makita's collaboration.

Top Co-Authors

Avatar

Takuji Iwase

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Futoshi Akiyama

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Goi Sakamoto

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Seiichiro Nishimura

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Masataka Yoshimoto

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Rie Horii

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Yumi Miyagi

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Hidetomo Morizono

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Keiichiro Tada

Japanese Foundation for Cancer Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge